#feed - Shift.ms

Forum

We are a charity and rely on donations

Charity Number: 1117194 (England and Wales)

Registered Company: 06000961

Registered address:
Shift.ms, Platform, New Station Street, LS1 4JB, United Kingdom

London office:
Shift.ms, Somerset House, Strand, West Goods Entrance, London WC2R 1LA, United Kingdom

©2026 Shift.ms

Sort 15232 results by

Feedback

For the past two days, both of my eyes have been red. I’m not sure whether this is because of MS or if it is some kind of infection. When I was first diagnosed with Multiple Sclerosis, my eyes also became red at that time, and the vision in one eye decreased due to optic neuritis.

First posted on the Shift.ms app

Last reply

Member feedback sessions are open 🥳

Hey! If we haven’t met yet, I’m a UX Designer in our app development team, and I’m inviting you to help shape what we build next. We’re hosting weekly 30-minute feedback sessions to chat with members about their experience - what’s working, what’s not, and what could be even better. Your feedback d...

First posted on the Shift.ms app

Last reply

I would love some feedback from people who have had RRMS and have progressed to SPMS. I was recently rediagnosed. I know MS is different for each individual but I’m wondering what I might expect the future to be like for me.

First posted on the Shift.ms app

Last reply

VUMERITY- FEEDBACK AND THOUGHTS

Hello all! I have been discussing changing my DMT from Tecfidera to Vumerity with my amazing MS Nurse. I would like to hear from others, what their thoughts are on Vumerity,and any experience that you've had whilst taking it. Any thoughts/advice/problems would be welcome. It will all enable me t...

Hastings, United Kingdom

First posted on the Shift.ms app

Last reply

Hi I'm new here and I'm wondering if anybody's experienced eye issues this is the first for me. I've been diagnosed since 2007. Most of my lesions are in my brain and my spinal cord on the top. And I didn't have any eye pain but I had like lights sparkle flashing I had a blackout in my right eye for about 30 minutes the first day the second day it was only a few minutes and then the third day my eye was swollen shut. I went to the hospital for 3 days they put me on steroids ruled out a stroke. There was only a visiting neurologist because I was out of state and they had no answers so just curious if anybody can give me any feedback on that thank you..❤️

First posted on the Shift.ms app

Last reply

Has anyone had HSCT stem cell treatments and what were your results? Thinking about getting it done. Thanks for any feedback you can provide.

First posted on the Shift.ms app

3:14•NEWSHEALTH & MEDICINEFinding immune cells that stop a body from attacking itself wins medicine NobelThe 2025 prize goes to 3 researchers who ID'd T-regs and their role in autoimmune diseaseMary Brunkow (left), Fred Ramsdell (middle) and Shimon Sakaguchi (right) have won the Nobel Prize in physiology or medicine for discovering regulatory T cells, which keep the immune system from attacking the body.NIKLAS ELMEHED © NOBEL PRIZE OUTREACH 3:15Work on peacemakers in the immune system won the 2025 Nobel Prize in physiology or medicine.The peacemakers are regulatory T cells, a type of immune cell that calms the immune system after it has finished fighting infection or healing a wound.These special T cells also prevent the immune system from attacking the body. If they fail in this mission, autoimmune disorders or damaging inflammation can result. These cells are also important to prevent rejection of the fetus during pregnancy.3:15•Shimon Sakaguchi of Osaka University in Japan first discovered these important cells, also known as T-regs, in 1995. Sakaguchi shares the prize, worth 11 million Swedish kronor (over $1.1 million), with Mary Brunkow of the Institute for Systems Biology in Seattle and Fred Ramsdell, a cofounder of Sonoma Biotherapeutics, a company based in San Francisco and Seattle. The Nobel Assembly at the Karolinska Institute in Stockholm announced the prize October 6.Brunkow and Ramsdell tracked down a mutation that caused a fatal autoimmune disease in male mouse pups while working at Celltech Chiroscience in Bothell, Wash., in the 1990s. The mutation turned out to disable a gene called FOXP3. That gene is important for T-reg development, Sakaguchi later discovered. Without it, there aren't enough T-regs to stop 3:15のthere aren't enough T-regs to stop wayward immune cells from causing harm in the body. Mutations in FOXP3 are also responsible for an autoimmune disease called IPEX in people, the American duo revealed in 2001.Scientists are learning to harness T-regs to prevent rejection of transplanted organs and treat autoimmune disorders, food allergies, cancer and other conditions in which the immune system is overactive or directed against the wrong thing.Questions or comments on this article? E-mail usat [email protected]/

First posted on the Shift.ms app

Unpublished

Finding immune cells that stop a body from attacking itself wins medicine NobelThe 2025 prize goes to 3 researchers who ID'd T-regs and their role in autoimmune diseaseMary Brunkow (left), Fred Ramsdell (middle) and Shimon Sakaguchi (right) have won the Nobel Prize in physiology or medicine for discovering regulatory T cells, which keep the immune system from attacking the body.NIKLAS ELMEHED © NOBEL PRIZE 3:15Work on peacemakers in the immune system won the 2025 Nobel Prize in physiology or medicine.The peacemakers are regulatory T cells, a type of immune cell that calms the immune system after it has finished fighting infection or healing a wound.These special T cells also prevent the immune system from attacking the body. If they fail in this mission, autoimmune disorders or damaging inflammation can result. These cells are also important to prevent rejection of the fetus during pregnancy.3:15•Shimon Sakaguchi of Osaka University in Japan first discovered these important cells, also known as T-regs, in 1995. Sakaguchi shares the prize, worth 11 million Swedish kronor (over $1.1 million), with Mary Brunkow of the Institute for Systems Biology in Seattle and Fred Ramsdell, a cofounder of Sonoma Biotherapeutics, a company based in San Francisco and Seattle. The Nobel Assembly at the Karolinska Institute in Stockholm announced the prize October 6.Brunkow and Ramsdell tracked down a mutation that caused a fatal autoimmune disease in male mouse pups while working at Celltech Chiroscience in Bothell, Wash., in the 1990s. The mutation turned out to disable a gene called FOXP3. That gene is important for T-reg development, Sakaguchi later discovered. Without it, there aren't enough T-regs to stop wayward immune cells from causing 3:15のthere aren't enough T-regs to stop wayward immune cells from causing harm in the body. Mutations in FOXP3 are also responsible for an autoimmune disease called IPEX in people, the American duo revealed in 2001.Scientists are learning to harness T-regs to prevent rejection of transplanted organs and treat autoimmune disorders, food allergies, cancer and other conditions in which the immune system is overactive or directed against the wrong thing.Questions or comments on this article? E-mail usat [email protected]/

First posted on the Shift.ms app

Hey MS Family, Have Any Of You Tried The Cladribine (Mavenclad) Medication Before? … If So Then Any Feedback Would Be Greatly Appreciated As I’m Being Put On It In 2 Weeks … Thank You

March, United Kingdom

First posted on the Shift.ms app

Good news for us all. Finding immune cells that stop a body from attacking itself wins medicine NobelThe 2025 prize goes to 3 researchers who ID'd T-regs and their role in autoimmune diseaseMary Brunkow (left), Fred Ramsdell (middle) and Shimon Sakaguchi (right) have won the Nobel Prize in physiology or medicine for discovering regulatory T cells, which keep the immune system from attacking the body.NIKLAS ELMEHED © NOBEL PRIZE OUTREACHYou have three complimentary articles left Work on peacemakers in the immune system won the 2025 Nobel Prize in physiology or medicine.The peacemakers are regulatory T cells, a type of immune cell that calms the immune system after it has finished fighting infection or healing a wound.These special T cells also prevent the immune system from attacking the body. If they fail in this mission, autoimmune disorders or damaging inflammation can result. These cells are also important to prevent rejection of the fetus during pregnancy. Shimon Sakaguchi of Osaka University in Japan first discovered these important cells, also known as T-regs, in 1995. Sakaguchi shares the prize, worth 11 million Swedish kronor (over $1.1 million), with Mary Brunkow of the Institute for Systems Biology in Seattle and Fred Ramsdell, a cofounder of Sonoma Biotherapeutics, a company based in San Francisco and Seattle. The Nobel Assembly at the Karolinska Institute in Stockholm announced the prize October 6.Brunkow and Ramsdell tracked down a mutation that caused a fatal autoimmune disease in male mouse pups while working at Celltech Chiroscience in Bothell, Wash., in the 1990s. The mutation turned out to disable a gene called FOXP3. That gene is important for T-reg development, Sakaguchi later discovered. Without it, wayward immune cells from causing harm in the body. Mutations in FOXP3 are also responsible for an autoimmune disease called IPEX in people, the American duo revealed in 2001.Scientists are learning to harness T-regs to prevent rejection of transplanted organs and treat autoimmune disorders, food allergies, cancer and other conditions in which the immune system is overactive or directed against the wrong thing.Questions or comments on this article? E-mail usat [email protected]/. Sorry if this is not continuous but I was copying and pasting the article to try to showcase it.

First posted on the Shift.ms app